Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Nanoprecipitation Method for Formulating Nanoparticles

Posted on By

SOP for Nanoprecipitation Method for Formulating Nanoparticles

Standard Operating Procedure for Nanoprecipitation Method in Nanoparticle Formulation

1) Purpose

This SOP outlines the nanonprecipitation method for preparing nanoparticles, typically used to create polymer-based nanoparticles for drug delivery. The technique allows for the formation of nanoparticles by precipitation from a solution.

2) Scope

This SOP applies to laboratory personnel responsible for the formulation of nanoparticles using the nanonprecipitation method.

3) Responsibilities

  • Operators: Responsible for following the nanonprecipitation protocol and ensuring accurate nanoparticle formation.
  • QA: Ensures the nanoparticles meet the required quality standards.

4) Procedure

4.1 Polymer Solution Preparation

4.1.1 Polymer Selection

  • 4.1.1.1 Select an appropriate polymer (e.g., PLGA) and dissolve it in a water-miscible organic solvent (e.g., acetone or ethanol).
  • 4.1.1.2 Stir until the polymer is completely dissolved.
See also  SOP for Formulation of Nanoparticles for Vaccine Delivery

4.2 Precipitation Process

4.2.1 Addition of Polymer Solution

  • 4.2.1.1 Slowly add the polymer solution into an aqueous phase containing stabilizers under gentle stirring to form nanoparticles by precipitation.
  • 4.2.1.2 Maintain the stirring rate until the nanoparticles have formed, typically over a period of 10–15 minutes.

4.2.2 Particle Size Control

  • 4.2.2.1 Monitor particle size using dynamic light scattering (DLS) to ensure the nanoparticles are within the desired size range.

4.3 Washing and Purification

4.3.1 Centrifugation

  • 4.3.1.1 Centrifuge the nanoparticle suspension at 10,000 g to collect the nanoparticles and discard the supernatant.
  • 4.3.1.2 Wash the nanoparticles with distilled water
and repeat the centrifugation process.

4.4 Drying and Storage

4.4.1 Drying

  • 4.4.1.1 Freeze-dry or vacuum-dry the nanoparticles, depending on the formulation requirements.

4.4.2 Storage

  • 4.4.2.1 Store the dried nanoparticles in sterile containers at 4°C or room temperature.

5) Abbreviations, if any

  • PLGA: Poly(lactic-co-glycolic acid)
  • DLS: Dynamic Light Scattering

6) Documents, if any

  • Nanoprecipitation Process Logbook

7) References, if any

  • Guidelines for nanoprecipitation methods in nanoparticle formulation

8) SOP Version

Version 1.0

Annexure

Nanoprecipitation Process Logbook Template

Date Batch Number Polymer Type Particle Size Encapsulation Efficiency Operator Initials QA Initials
DD/MM/YYYY Batch Number Polymer Name Size in nm % Encapsulation Operator Name QA Name
           
See also  SOP for Lyophilization of Nanoparticle-Based Formulations
Nanoparticle Formulation Tags:Nanoparticle biomedical applications SOP, Nanoparticle clinical trial SOP, Nanoparticle encapsulation SOP, Nanoparticle formulation SOP, Nanoparticle handling SOP, Nanoparticle preparation procedure, Nanoparticle production SOP, Nanoparticle quality control SOP, Nanoparticle size optimization SOP, Nanoparticle SOP, Nanoparticle stability testing SOP, Nanoparticle standard operating procedures, Nanoparticle sterilization SOP, Nanoparticle storage SOP, Nanoparticle surface modification SOP, Nanoparticle synthesis SOP, Nanoparticle toxicology SOP, SOP for nanomaterials, SOP for nanoparticle characterization, SOP for nanoparticle drug delivery, SOP for nanoparticle gene delivery, SOP for nanoparticle regulatory compliance, SOP for nanoparticle safety, SOP for nanoparticle scaling, SOP for targeted drug delivery nanoparticles

Post navigation

Previous Post: SOP for Preparing Nasal Sprays with Essential Oils
Next Post: Lyophilized Products : SOP for Use of Cryoprotectants in Lyophilized Products

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version